یکشنبه 22 شهریور 1405
[Archive]
پذیرفته شده و در حال انتشار
برگشت به فهرست مقالات |
برگشت به فهرست نسخه ها
چکیده: (388 مشاهده)
Background and Objective: Enterococcus faecalis is strongly associated with persistent endodontic infections and has been reported in 24–77% of failed root canal treatments due to its ability to survive harsh environments, penetrate dentinal tubules, and form mature biofilms. Calcium hydroxide (Ca (OH)₂) is widely used as an intracanal medicament but often fails to eliminate E. faecalis. Totarol, a natural phenolic diterpene, exhibits potent antibacterial activity against Gram-positive bacteria. The aim of this study was to compare the antibacterial and antibiofilm effects of totarol and Ca(OH)₂ against clinically isolated E. faecalis using in vitro testing and an ex vivo 21-day biofilm model.
Materials and Methods: Clinical isolates were microbiologically confirmed. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of totarol were determined using broth dilution and expressed in volumetric units due to formulation constraints. Agar diffusion assay was performed (n=10/group). A 21-day intraradicular biofilm model was developed in human teeth followed by 3-day intracanal medication using commercial Ca (OH)₂ paste and totarol. Dentin shavings were collected from standardized canal walls, and colony forming units (CFU) were quantified and analyzed statistically.
Results: Totarol (MBC 22.5 µl/ml) produced a significantly larger inhibition zone (38.26 ± 1.84 mm) than Ca (OH)₂ (15.69 ± 1.73 mm; p<0.0001). In the biofilm model, totarol reduced bacterial load by 97.8%, significantly greater than Ca (OH)₂ (81.1%; p<0.0001, n=10).
Conclusion: Totarol demonstrated a substantially greater antibacterial and antibiofilm effect than Ca (OH)₂ and may represent a potential adjunct intracanal medicament for persistent infections, pending further biological and clinical evaluation.
فهرست منابع
1. Siqueira Jr JF, Rôças IN. Present status and future directions: Microbiology of endodontic infections. Int Endodont J. 2022;55:512-30. [DOI:10.1111/iej.13677] [PMID]
2. Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endodont. 2006;32(2):93-8. [DOI:10.1016/j.joen.2005.10.049] [PMID]
3. Hyeon GE, Eom YB. Totarol exhibits antibacterial effects through antibiofilm and combined interaction against vancomycin-resistant Enterococcus faecalis. Canadian J Microbiol. 2024;70(10):426-32. [DOI:10.1139/cjm-2024-0014] [PMID]
4. Wong J, Manoil D, Näsman P, Belibasakis GN, Neelakantan P. Microbiological aspects of root canal infections and disinfection strategies: an update review on the current knowledge and challenges. Front Oral Health. 2021;2:672887. [DOI:10.3389/froh.2021.672887] [PMID] [PMCID]
5. Kim D, Kim E. Antimicrobial effect of calcium hydroxide as an intracanal medicament in root canal treatment: a literature review-Part I. In vitro studies. Restorat Dentist Endodont. 2014;39(4):241-52. [DOI:10.5395/rde.2014.39.4.241] [PMID] [PMCID]
6. Teja KV, Janani K, Srivastava KC, Shrivastava D, Natoli V, Di Blasio M, et al. Comparative evaluation of antimicrobial efficacy of different combinations of calcium hydroxide against Enterococcus faecalis. BMC Oral Health. 2023;23(1):849. [DOI:10.1186/s12903-023-03552-4] [PMID] [PMCID]
7. Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endodont J. 2002;35(3):221-8. [DOI:10.1046/j.1365-2591.2002.00504.x] [PMID]
8. Allerton F, Nuttall T. Antimicrobial use: importance of bacterial culture and susceptibility testing. In Practice. 2021;43(9):500-10. [DOI:10.1002/inpr.139]
9. Wayne P. Clinical and laboratory standards institute (CLSI). Performance standards for antimicrobial susceptibility testing. 2015;30.
10. Chikezie IO. Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) using a novel dilution tube method. African J Microbiol Res. 2017;11(23):977-80. [DOI:10.5897/AJMR2017.8545]
11. Gajan EB, Shirmohammadi A, Aghazadeh M, Alizadeh M, Deljavan AS, Ahmadpour F. Antibiotic resistance in Enterococcus faecalis isolated from hospitalized patients. J Dent Res Dent Clin Dent Prospect. 2013;7(2):102.
12. Jan H, Khan MA, Usman H, Shah M, Ansir R, Faisal S, et al. The Aquilegia pubiflora (Himalayan columbine) mediated synthesis of nanoceria for diverse biomedical applications. RSC Adv. 2020;10(33):19219-31. [DOI:10.1039/D0RA01971B] [PMID] [PMCID]
13. Hossain TJ. Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations. Eur J Microbiol Immunol (Bp). 2024;14(2):97-115. [DOI:10.1556/1886.2024.00035] [PMID] [PMCID]
14. Sirén EK, Kerosuo E, Lavonius E, Meurman JH, Haapasalo M. Ca(OH)2 application modes: in vitro alkalinity and clinical effect on bacteria. Int Endodont J. 2014;47(7):628-38. [DOI:10.1111/iej.12199] [PMID]
15. Al-Huwaizi H, Al-Rubayi A, Al-Najjar A. The use of acetic acid as a new intracanal medicament, a bacteriological, histopathological, and clinical study: Ph. D. thesis, College of Dentistry. Baghdad; 2000.
16. Ballal V, Kundabala M, Acharya S, Ballal M. Antimicrobial action of calcium hydroxide, chlorhexidine and their combination on endodontic pathogens. Australian Dent J. 2007;52(2):118-21. [DOI:10.1111/j.1834-7819.2007.tb00475.x] [PMID]
17. Mohammadi Z, Abbott P. The properties and applications of chlorhexidine in endodontics. Int Endodont J. 2009;42(4):288-302. [DOI:10.1111/j.1365-2591.2008.01540.x] [PMID]
18. Zehnder M. Root canal irrigants. J Endodont. 2006;32(5):389-98. [DOI:10.1016/j.joen.2005.09.014] [PMID]
19. Haapasalo M, Ørstavik D. In vitro infection and of dentinal tubules. J Dent Res. 1987;66(8):1375-9. [DOI:10.1177/00220345870660081801] [PMID]
20. Yang S, Meng X, Zhen Y, Baima Q, Wang Y, Jiang X, et al. Strategies and mechanisms targeting Enterococcus faecalis biofilms associated with endodontic infections: a comprehensive review. Front Cell Infect Microbiol. 2024;14:1433313. [DOI:10.3389/fcimb.2024.1433313] [PMID] [PMCID]
21. Shi C, Zhao X, Li W, Meng R, Liu Z, Liu M, et al. Inhibitory effect of totarol on exotoxin proteins hemolysin and enterotoxins secreted by Staphylococcus aureus. W J Microbiol Biotechnol. 2015;31(10):1565-73. [DOI:10.1007/s11274-015-1905-3] [PMID]
22. Shi C, Che M, Zhang X, Liu Z, Meng R, Bu X, et al. Antibacterial activity and mode of action of totarol against Staphylococcus aureus in carrot juice. J Food Sci Technol. 2018;55(3):924-34. [DOI:10.1007/s13197-017-3000-2] [PMID] [PMCID]
23. Swaroop AE, Mathew S, Harshini P, Nagaraja S. Local drug delivery for regeneration and disinfection in endodontics: A narrative review. J Conservat Dentist Endodont. 2025;28(2):119-25. [DOI:10.4103/JCDE.JCDE_801_24] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
